| Polypharmacy of schizophrenia. | |
| | |
MedLine Citation:
|
PMID: 20877529 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
In this article, we investigated the current practice for treatment of schizophrenia. According to our data, physicians consider one-product regimens 53 percent of the time. Two-product regimens are considered 29 percent of the time, and regimens of three or more products are considered 18 percent of the time. At the point of the patient visit, antipsychotic medications comprise 97 percent of treatment regimens. Fifty-six percent of treatment regimens involve only antipsychotic medications. Classes used to supplement antipsychotic medications in the treatment of schizophrenia include antidepressants (20%), mood stabilizers (15%), anti-anxiety (7%) drugs, and drugs to treat extrapyramidal symptoms (6%). An expert commentary is also included with the data. |
| | |
Authors:
|
Peter Dussias; Amir H Kalali; Leslie Citrome |
Related Documents
:
|
1347939 - The stimulants. 12058839 - Medical disorders among inpatients with autism in denmark according to icd-8: a nationw... 10570699 - Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactiv... 16870959 - Baseline use of concomitant psychotropic medications to treat schizophrenia in the cati... 19786909 - Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-i disorder. 12679589 - Cognitive inhibition and thought disorder in schizophrenia. 16402509 - Ritual male circumcision: a brief history. 10429639 - Professionalism in emergency medicine. 21861909 - Effects of shared medical appointments on quality of life and cost-effectiveness for pa... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Psychiatry (Edgmont (Pa. : Township)) Volume: 7 ISSN: 1555-5194 ISO Abbreviation: Psychiatry (Edgmont) Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-09-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101484252 Medline TA: Psychiatry (Edgmont) Country: United States |
Other Details:
|
Languages: eng Pagination: 17-9 Citation Subset: - |
Affiliation:
|
Mr. Dussias is Executive Director, Strategic Analytics, Commercial Solutions, Quintiles, Inc., Parsippany, New Jersey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ledderhose disease: an unusual presentation.
Next Document: Yoga as a complementary therapy for children and adolescents: a guide for clinicians.